Patient access to orphan drugs in France

被引：0
|
作者：
Marion Bourdoncle
Blandine Juillard-Condat
Florence Taboulet
机构：
[1] CHU de Toulouse,Department of pharmacy
[2] INSERM UMR 1027,undefined
[3] Toulouse,undefined
[4] University of Toulouse III,undefined
来源：
Orphanet Journal of Rare Diseases | / 14卷
关键词：
Orphan drugs; Rare disease; Patient access; Availability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Patient access to orphan drugs in France
    Bourdoncle, Marion
    Juillard-Condat, Blandine
    Taboulet, Florence
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [2] Patient access to orphan drugs
    Cohen, Joshua P.
    Awatin, Josephine G.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (12): : 923 - 932
  • [3] ORPHAN DRUGS IN FRANCE: KEY MARKET ACCESS INCENTIVES
    Mennezein, L.
    Avot, D.
    Laigle, V
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A565 - A565
  • [4] Analysis of patient access to orphan drugs in Turkey
    Güvenç Koçkaya
    Sibel Atalay
    Gülpembe Oğuzhan
    Mustafa Kurnaz
    Selin Ökçün
    Çiğdem Sar Gedik
    Mete Şaylan
    Nazlı Şencan
    [J]. Orphanet Journal of Rare Diseases, 16
  • [5] Analysis of patient access to orphan drugs in Turkey
    Kockaya, Guvenc
    Atalay, Sibel
    Oguzhan, Gulpembe
    Kurnaz, Mustafa
    Okcun, Selin
    Sar Gedik, Cigdem
    Saylan, Mete
    Sencan, Nazli
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [6] Orphan drugs: pricing, reimbursement and patient access
    Barak, Adam
    Nandi, Jyoti Shankar
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2011, 5 (04) : 299 - 317
  • [7] ACCESS TO ORPHAN ONCOLOGY DRUGS IN FRANCE VERSUS THE UNITED KINGDOM
    Esmail, S.
    Grosvenor, A. S.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A18 - A18
  • [8] Orphan drugs in France (2001-2005): Access to information and characteristics
    Baumevieille, Marie
    Daveluy, Amelie
    Aulois-Griot, Marine
    Haramburu, Francoise
    [J]. THERAPIE, 2007, 62 (01): : 9 - 16
  • [9] CHANGES TO EARLY ACCESS SCHEME IN FRANCE: EARLY LEARNINGS FOR ORPHAN DRUGS
    Sostar, J.
    Faivre, P.
    Herscu, P.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S242 - S242
  • [10] International differences in patient access to ultra-orphan drugs
    Kanters, Tim A.
    Redekop, W. Ken
    Hakkaart, Leona
    [J]. HEALTH POLICY AND TECHNOLOGY, 2018, 7 (01) : 57 - 64
12345